[Skip to Content]
[Skip to Content Landing]
Comment & Response
September 23, 2013

If Less Is More, Which Outcomes Should Be Presented in Facilitating Prostate Cancer Screening Decision Making?—Reply

Author Affiliations
  • 1Cecil G. Sheps Center for Health Services Research and Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
  • 2Department of Medicine, University of North Carolina at Chapel Hill
JAMA Intern Med. 2013;173(17):1657. doi:10.1001/jamainternmed.2013.8132

In Reply Partin and Powell raise an important issue in decision making: what is the optimal amount and type of information that patients should consider in a decision support intervention? They suggest that 2 of the types of information we presented, information about risk of mortality from prostate cancer and information about the risks associated with treatment complications, are the most important, while the other 2 (risk of undergoing a biopsy as a result of screening and risk of being [over]diagnosed) seem less important to them.

First Page Preview View Large
First page PDF preview
First page PDF preview